Annual CFF
$71.93 M
+$71.75 M+40539.55%
31 December 2023
Summary:
Black Diamond Therapeutics annual cash flow from financing activities is currently $71.93 million, with the most recent change of +$71.75 million (+40539.55%) on 31 December 2023. During the last 3 years, it has fallen by -$143.01 million (-66.53%). BDTX annual CFF is now -66.53% below its all-time high of $214.94 million, reached on 31 December 2020.BDTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$252.00 K
-$21.63 M-101.18%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly cash flow from financing activities is currently -$252.00 thousand, with the most recent change of -$21.63 million (-101.18%) on 30 September 2024. Over the past year, it has dropped by -$72.18 million (-100.35%). BDTX quarterly CFF is now -100.12% below its all-time high of $213.84 million, reached on 31 March 2020.BDTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$25.21 M
-$72.18 M-74.11%
30 September 2024
Summary:
Black Diamond Therapeutics TTM cash flow from financing activities is currently $25.21 million, with the most recent change of -$72.18 million (-74.11%) on 30 September 2024. Over the past year, it has dropped by -$46.74 million (-64.96%). BDTX TTM CFF is now -92.62% below its all-time high of $341.67 million, reached on 30 June 2020.BDTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -100.3% | -65.0% |
| 3 y3 years | -66.5% | -493.8% | +1517.1% |
| 5 y5 years | +37.5% | -100.6% | -43.0% |
BDTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.5% | >+9999.0% | -100.3% | at low | -74.1% | >+9999.0% |
| 5 y | 5 years | -66.5% | >+9999.0% | -100.1% | at low | -92.6% | >+9999.0% |
| alltime | all time | -66.5% | >+9999.0% | -100.1% | at low | -92.6% | >+9999.0% |
Black Diamond Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$252.00 K(-101.2%) | $25.21 M(-74.1%) |
| June 2024 | - | $21.38 M(+417.6%) | $97.39 M(+28.1%) |
| Mar 2024 | - | $4.13 M(-9078.3%) | $76.01 M(+5.7%) |
| Dec 2023 | $71.93 M(>+9900.0%) | -$46.00 K(-100.1%) | $71.93 M(-0.0%) |
| Sept 2023 | - | $71.93 M(>+9900.0%) | $71.95 M(>+9900.0%) |
| June 2023 | - | $0.00(-100.0%) | $75.00 K(0.0%) |
| Mar 2023 | - | $51.00 K(-282.1%) | $75.00 K(-57.6%) |
| Dec 2022 | $177.00 K(-75.7%) | -$28.00 K(-153.8%) | $177.00 K(-13.7%) |
| Sept 2022 | - | $52.00 K(>+9900.0%) | $205.00 K(-5.5%) |
| June 2022 | - | $0.00(-100.0%) | $217.00 K(-45.9%) |
| Mar 2022 | - | $153.00 K(>+9900.0%) | $401.00 K(-45.0%) |
| Dec 2021 | $729.00 K | $0.00(-100.0%) | $729.00 K(-53.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $64.00 K(-65.2%) | $1.56 M(-11.7%) |
| June 2021 | - | $184.00 K(-61.7%) | $1.76 M(+11.6%) |
| Mar 2021 | - | $481.00 K(-42.0%) | $1.58 M(-99.3%) |
| Dec 2020 | $214.94 M(+68.2%) | $830.00 K(+207.4%) | $214.94 M(-27.8%) |
| Sept 2020 | - | $270.00 K(>+9900.0%) | $297.61 M(-12.9%) |
| June 2020 | - | $0.00(-100.0%) | $341.67 M(+0.0%) |
| Mar 2020 | - | $213.84 M(+156.1%) | $341.60 M(+167.4%) |
| Dec 2019 | $127.76 M(+144.2%) | $83.50 M(+88.3%) | $127.76 M(+188.6%) |
| Sept 2019 | - | $44.33 M(<-9900.0%) | $44.26 M(<-9900.0%) |
| June 2019 | - | -$70.00 K(<-9900.0%) | -$70.00 K(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $52.31 M(+424.5%) | - | - |
| Dec 2017 | $9.97 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual CFF year-on-year change?
- What is Black Diamond Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly CFF year-on-year change?
- What is Black Diamond Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM CFF year-on-year change?
What is Black Diamond Therapeutics annual cash flow from financing activities?
The current annual CFF of BDTX is $71.93 M
What is the all time high annual CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual cash flow from financing activities is $214.94 M
What is Black Diamond Therapeutics annual CFF year-on-year change?
Over the past year, BDTX annual cash flow from financing activities has changed by +$71.75 M (+40539.55%)
What is Black Diamond Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BDTX is -$252.00 K
What is the all time high quarterly CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly cash flow from financing activities is $213.84 M
What is Black Diamond Therapeutics quarterly CFF year-on-year change?
Over the past year, BDTX quarterly cash flow from financing activities has changed by -$72.18 M (-100.35%)
What is Black Diamond Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BDTX is $25.21 M
What is the all time high TTM CFF for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM cash flow from financing activities is $341.67 M
What is Black Diamond Therapeutics TTM CFF year-on-year change?
Over the past year, BDTX TTM cash flow from financing activities has changed by -$46.74 M (-64.96%)